BioFluidica to Introduce Next-Generation Biomarker Isolation Platform

LiquidScan™ at the 2022 American Association for Cancer Research Meeting in New Orleans BioFluidica LiquidScan Harnesses the Power of Microfluidics SAN DIEGO, April 5, 2022 /PRNewswire/ — Biofluidica, Inc., a privately held biotechnology company, today announced they will be introducing…

Click here to view original post